Anyone sourcing research peptides eventually runs into the same two acronyms: HPLC and MS. They show up on product pages, in Certificates of Analysis, and in nearly every conversation about peptide quality. But what do they actually measure, and why does the difference between “99% pure” and “confirmed as the right molecule” matter? Understanding how these two analytical methods work is one of the most useful things a research buyer can learn before evaluating a supplier.

HPLC: Measuring How Much of the Sample Is the Target Compound

High-Performance Liquid Chromatography (HPLC) is the workhorse method for quantifying purity. In simple terms, a small amount of the peptide sample is dissolved and pushed through a column packed with a stationary material under high pressure. In the reverse-phase HPLC (RP-HPLC) format most commonly used for peptides, the column material is non-polar while the liquid carrying the sample (the mobile phase) gradually becomes more organic — typically increasing acetonitrile content over the course of the run.

Different molecules in the sample interact with the column to different degrees based on their hydrophobicity, so they travel at different speeds and exit (“elute”) at different times. A detector — usually UV-Vis, tuned to wavelengths absorbed by aromatic amino acids like tyrosine, tryptophan, and phenylalanine — records each compound as it elutes, producing a chromatogram: a plot of absorbance over time with a series of peaks.

The target peptide should produce one large, well-defined peak. Anything else — truncated sequences from incomplete synthesis, deletion or addition products, oxidized variants, or leftover reagents — shows up as smaller peaks elsewhere on the trace. Purity is then calculated as area percent:

Purity (%) = (area of the target peak ÷ total area of all peaks) × 100

This is why a Certificate of Analysis often states something like “99.4% purity by HPLC” alongside the chromatogram itself. It’s worth understanding what that number does and doesn’t capture. HPLC area percent reflects the proportion of UV-absorbing material that co-elutes as the main peak under specific run conditions — column, gradient, wavelength. It does not account for non-UV-absorbing residues such as water content or counter-ions (like acetate or TFA) left from purification, which can make up a real portion of a vial’s total mass even when the peptide itself tests at high purity. HPLC purity is a statement about the composition of the peptide-related material in the sample, not a complete mass balance of the vial.

Mass Spectrometry: Confirming Identity, Not Just Purity

HPLC tells you how clean a sample is, but a sharp, symmetrical peak alone doesn’t prove which molecule produced it. That’s where mass spectrometry (MS) comes in. MS ionizes the sample and measures the mass-to-charge ratio (m/z) of the resulting ions, producing a spectrum of peaks corresponding to different ionized species.

For peptides, the observed mass is compared against the theoretical mass calculated from the intended amino acid sequence. If they match within an acceptable tolerance, identity is confirmed at the molecular level — verifying that the vial actually contains the compound it’s labeled as, rather than a different peptide, a truncated fragment, or a byproduct that happens to elute at a similar time on HPLC.

In practice, MS is frequently paired directly with HPLC in a technique called LC-MS: as each compound elutes from the column, it flows straight into the mass spectrometer, so a single run generates both a purity chromatogram and a mass spectrum for the same peak. More advanced tandem MS/MS approaches go further, fragmenting the peptide and reading fragment ion series to help confirm the amino acid sequence itself, not just the overall molecular weight. HPLC and MS answer two complementary questions: HPLC asks how much of the sample is one consistent thing, and MS asks whether that consistent thing is the molecule it’s supposed to be.

What a Certificate of Analysis Should Actually Contain

A Certificate of Analysis (COA) is the document that ties these test results to a specific manufactured batch. A COA worth relying on typically includes:

Purity and identity testing matter beyond a number on a label. In a research setting, reproducibility depends on knowing that the compound used in one experiment is chemically identical to the compound used in a follow-up experiment or by a collaborator elsewhere. Batch-to-batch variability or unexpected byproducts can introduce confounding variables, making it harder to attribute an observed effect to the intended compound rather than an impurity. This is why credible suppliers test every batch rather than relying on a single validation study for a product line.

What Buyers Should Look For in a Supplier’s Testing Claims

When evaluating a research peptide supplier, a purity percentage alone is not enough to assess rigor. It’s worth checking for:

Great Lakes Peptide Co. verifies its research peptides using HPLC and mass spectrometry as a standard part of its quality process, consistent with the practices described above. This article is intended as general background on how these analytical methods work, not as a substitute for reviewing the specific documentation provided with any given batch.


This article is provided for general educational and research-informational purposes only and does not constitute medical, clinical, or health advice. All products sold by Great Lakes Peptide Co. are supplied strictly for laboratory research use only and are not intended for human or veterinary use, consumption, or application of any kind.

Leave a Reply

Your email address will not be published. Required fields are marked *